Samira M. Azarin

Samira M. Azarin

Auto-generated profile, based on publicly available information

Samira M. Azarin

University of Minnesota

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
BBBrandon J. Burbach
Brandon J. Burbach
SOStephen D. O’fLanagan
Stephen D. O’fLanagan
QSQi Shao
Qi Shao
KYKatharine M. Young
Katharine M. Young
JSJoseph R. Slaughter
Joseph R. Slaughter
YSYoji Shimizu
Yoji Shimizu
Memory CD8+ T cells populate non-lymphoid tissues (NLTs) following pathogen infection, but little is known about the establishment of endogenous tumor-specific tissue-resident memory T cells (TRM) during cancer immunotherapy. Using a transplantable mouse model of prostate carcinoma, here we report that tumor challenge leads to expansion of naïve neoantigen-specific CD8+ T cells and formation of a small population of non-recirculating TRM in several NLTs. Primary tumor destruction by irreversible electroporation (IRE), followed by anti-CTLA-4 immune checkpoint inhibitor (ICI), promotes robust expansion of tumor-specific CD8+ T cells in blood, tumor, and NLTs. Parabiosis studies confirm that TRM establishment following dual therapy is associated with tumor remission in a subset of cases and protection from subsequent tumor challenge. Addition of anti-PD-1 following dual IRE + anti-CTLA-4 treatment blocks tumor growth in non-responsive cases. This work indicates that focal tumor destruction using IRE combined with ICI is a potent in situ tumor vaccination strategy that generates protective tumor-specific TRM.

1 May 2018 in Tissue Engineering Part C: Methods
Verified
Journal Article
Closed access
RLRui Li
Rui Li
GYGuanglin Yu
Guanglin Yu
SASamira M. Azarin
Samira M. Azarin
AHAllison Hubel
Allison Hubel
Inadequate preservation methods of human induced pluripotent stem cells (hiPSCs) have impeded efficient reestablishment of cell culture after freeze-thaw. In this study, we examined the roles of cooling rate, seeding temperature and the difference between cell aggregates (3-50 cells) and single cells in controlled rate freezing of hiPSCs. Intracellular ice formation (IIF), post-thaw membrane integrity, cell attachment, apoptosis and cytoskeleton organization were evaluated to understand the different freezing responses between hiPSC single cells and aggregates, among cooling rates of 1, 3, 10˚C/min, and between seeding temperatures of -4, -8˚C. Raman spectroscopy images of ice showed that lower seeding temperature (-8˚C) did not affect IIF in single cells but significantly increased IIF in aggregates, suggesting higher sensitivity of aggregates to supercooling. In absence of IIF, Raman images showed greater variation of DMSO concentration across aggregates than single cells, suggesting cryoprotectant transport limitations in aggregates. Ability of cryopreserved aggregates to attach to culture substrates did not correlate with membrane integrity for the wide range of freezing parameters, indicating inadequacy of using only membrane integrity-based optimization metrics. Lower cooling rates (1, 3˚C/min) combined with higher seeding temperature (-4˚C) were better at preventing IIF and preserving cell function than higher cooling rate (10˚C/min) or lower seeding temperature (-8˚C), proving the seeding temperature range of -7 to -12˚C from literature to be suboptimal. Unique f-actin cytoskeletal organization into a honeycomb-like pattern was observed in post-passage and post-thaw colonies and correlated with successful reestablishment of cell culture.

3 August 2018 in Journal of Biological Engineering
Verified
Journal Article
Open access
PDF file
HLHak Rae Lee
Hak Rae Lee
FLFaith Leslie
Faith Leslie
SASamira M. Azarin
Samira M. Azarin
While hypoxia has been well-studied in various tumor microenvironments, its role in cancer cell dormancy is poorly understood, in part due to a lack of well-established in vitro and in vivo models. Hypoxic conditions under conventional hypoxia chambers are relatively unstable and cannot be maintained during characterization outside the chamber since normoxic response is quickly established. To address this challenge, we report a robust in vitro cancer dormancy model under a hypoxia-mimicking microenvironment using cobalt chloride (CoCl2), a hypoxia-mimetic agent, which stabilizes hypoxia inducible factor 1-alpha (HIF1α), a major regulator of hypoxia signaling. We compared cellular responses to CoCl2 and true hypoxia (0.1% O2) in different breast cancer cell lines (MCF-7 and MDA-MB-231) to investigate whether hypoxic regulation of breast cancer dormancy could be mimicked by CoCl2. To this end, expression levels of hypoxia markers HIF1α and GLUT1 and proliferation marker Ki67, cell growth, cell cycle distribution, and protein and gene expression were evaluated under both CoCl2 and true hypoxia. To further validate our platform, the ovarian cancer cell line OVCAR-3 was also tested. Our results demonstrate that CoCl2 can mimic hypoxic regulation of cancer dormancy in MCF-7 and MDA-MB-231 breast cancer cell lines, recapitulating the differential responses of these cell lines to true hypoxia in 2D and 3D. Moreover, distinct gene expression profiles in MCF-7 and MDA-MB-231 cells under CoCl2 treatment suggest that key cell cycle components are differentially regulated by the same hypoxic stress. In addition, the induction of dormancy in MCF-7 cells under CoCl2 treatment is HIF1α-dependent, as evidenced by the inability of HIF1α-suppressed MCF-7 cells to exhibit dormant behavior upon CoCl2 treatment. Furthermore, CoCl2 also induces and stably maintains dormancy in OVCAR-3 ovarian cancer cells. These results demonstrate that this CoCl2-based model could provide a widely applicable in vitro platform for understanding induction of cancer cell dormancy under hypoxic stress.

4 April 2018 in Fluids and Barriers of the CNS
Verified
Journal Article
Open access
PDF file
CLCatherine A. A. Lee
Catherine A. A. Lee
HSHannah S. Seo
Hannah S. Seo
AAAnibal G. Armien
Anibal G. Armien
FBFrank S. Bates
Frank S. Bates
JTJakub Tolar
Jakub Tolar
SASamira M. Azarin
Samira M. Azarin
X-linked adrenoleukodystrophy (X-ALD) is caused by mutations in the ABCD1 gene. 40% of X-ALD patients will convert to the deadly childhood cerebral form (ccALD) characterized by increased permeability of the brain endothelium that constitutes the blood–brain barrier (BBB). Mutation information and molecular markers investigated to date are not predictive of conversion. Prior reports have focused on toxic metabolic byproducts and reactive oxygen species as instigators of cerebral inflammation and subsequent immune cell invasion leading to BBB breakdown. This study focuses on the BBB itself and evaluates differences in brain endothelium integrity using cells from ccALD patients and wild-type (WT) controls. The blood–brain barrier of ccALD patients and WT controls was modeled using directed differentiation of induced pluripotent stem cells (iPSCs) into induced brain microvascular endothelial cells (iBMECs). Immunocytochemistry and PCR confirmed characteristic expression of brain microvascular endothelial cell (BMEC) markers. Barrier properties of iBMECs were measured via trans-endothelial electrical resistance (TEER), sodium fluorescein permeability, and frayed junction analysis. Electron microscopy and RNA-seq were used to further characterize disease-specific differences. Oil-Red-O staining was used to quantify differences in lipid accumulation. To evaluate whether treatment with block copolymers of poly(ethylene oxide) and poly(propylene oxide) (PEO–PPO) could mitigate defective properties, ccALD-iBMECs were treated with PEO–PPO block copolymers and their barrier properties and lipid accumulation levels were quantified. iBMECs from patients with ccALD had significantly decreased TEER (2592 ± 110 Ω cm2) compared to WT controls (5001 ± 172 Ω cm2). They also accumulated lipid droplets to a greater extent than WT-iBMECs. Upon treatment with a PEO–PPO diblock copolymer during the differentiation process, an increase in TEER and a reduction in lipid accumulation were observed for the polymer treated ccALD-iBMECs compared to untreated controls. The finding that BBB integrity is decreased in ccALD and can be rescued with block copolymers opens the door for the discovery of BBB-specific molecular markers that can indicate the onset of ccALD and has therapeutic implications for preventing the conversion to ccALD.

29 May 2021 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
HLHak Rae Lee
Hak Rae Lee
DKDae Woo Kim
Dae Woo Kim
VJVictoria O. Jones
Victoria O. Jones
YCYunkyu Choi
Yunkyu Choi
VFVivian E. Ferry
Vivian E. Ferry
SASamira M. Azarin
Samira M. Azarin

1 June 2018 in Biomaterials
Verified
Journal Article
Closed access
FPFrancisco Pelaez
Francisco Pelaez
NMNavid Manuchehrabadi
Navid Manuchehrabadi
Priyatanu RoyPriyatanu Roy
Priyatanu Roy
HNHarishankar Natesan
Harishankar Natesan
YWYiru Wang
Yiru Wang
SASamira M. Azarin
Samira M. Azarin